ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Maiden Holdings Ltd

Maiden Holdings Ltd (MHLA)

14.88
-0.54
( -3.50% )
Updated: 13:14:16

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
14.88
Bid
-
Ask
-
Volume
2,408
14.88 Day's Range 15.24
14.5655 52 Week Range 18.25
Market Cap
Previous Close
15.42
Open
15.24
Last Trade
11
@
14.98
Last Trade Time
13:10:37
Financial Volume
$ 36,124
VWAP
15.0016
Average Volume (3m)
1,989
Shares Outstanding
100,209,450
Dividend Yield
11.13%
PE Ratio
-5.38
Earnings Per Share (EPS)
-0.38
Revenue
89.23M
Net Profit
-38.57M

About Maiden Holdings Ltd

Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commerci... Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. The company has underwriting operations in Bermuda and the United States, along with business development teams in the United Kingdom, Germany, and other markets. Show more

Sector
Fire, Marine, Casualty Ins
Industry
Fire, Marine, Casualty Ins
Website
Headquarters
Pembroke, Bmu
Founded
1970
Maiden Holdings Ltd is listed in the Fire, Marine, Casualty Ins sector of the New York Stock Exchange with ticker MHLA. The last closing price for Maiden was $15.42. Over the last year, Maiden shares have traded in a share price range of $ 14.5655 to $ 18.25.

Maiden currently has 100,209,450 shares outstanding. The market capitalization of Maiden is $1.55 billion. Maiden has a price to earnings ratio (PE ratio) of -5.38.

MHLA Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-0.81515.4214.8341115.03909401CS
40.130.88135593220314.7515.5214.6145914.9913691CS
12-1.31-8.0914144533716.1916.1914.6198915.21090803CS
26-1.06-6.6499372647415.9417.2414.6208115.7480912CS
52-2.38-13.789107763617.2618.2514.5655301715.96349405CS
156-7.12-32.36363636362223.1713.57381518.37636871CS
260-1.36-8.3743842364516.2423.1710.89604719.14379883CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BFIBurgerFi International Inc
$ 0.5323
(149.79%)
278.38M
WINTWindtree Therapeutics Inc
$ 7.3513
(123.44%)
34.51M
RGCRegencell Bioscience Holdings Ltd
$ 13.15
(44.35%)
2.19M
CREVCarbon Revolution Public Ltd
$ 8.71
(41.17%)
7.5M
SGMOSangamo Therapeutics Inc
$ 0.9465
(40.85%)
107.15M
TANHTantech Holdings Ltd
$ 0.24334
(-50.33%)
5.87M
NMHINatures Miracle Holding Inc
$ 0.204
(-47.93%)
6.28M
DXCMDexCom Inc
$ 62.85
(-41.72%)
37.81M
POAIPredictive Oncology Inc
$ 1.3197
(-29.43%)
5.13M
PSIGPS International Group Ltd
$ 1.47
(-28.99%)
561.75k
BFIBurgerFi International Inc
$ 0.5323
(149.79%)
278.38M
SLNASelina Hospitality PLC
$ 0.0394
(4.79%)
228.9M
NVDANVIDIA Corporation
$ 114.18
(1.69%)
171.56M
SQQQProShares UltraPro Short QQQ
$ 8.9657
(-4.31%)
114.96M
SGMOSangamo Therapeutics Inc
$ 0.9465
(40.85%)
107.15M

Discussion

View Full Feed
rodeoup rodeoup 3 minutes ago
Probably alone on this, but glad to see the volume slow. This mining company is the real deal on all levels in my opinion. Put a quarter or so in the books from the perfect marriage of the Mt Vernon mine and the Bishop mill and watch the blue sky get brighter with organic growth!!!
NBRI
dstock07734 dstock07734 3 minutes ago
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
https://www.biospace.com/xcell-biosciences-strengthens-cell-and-gene-therapy-collaboration-with-labcorp

AmplifyBio and Xcell Biosciences Announce Partnership to Manufacture Solid Tumor-Targeting TCR-
NWBO
learningcurve2020 learningcurve2020 3 minutes ago
Yup. If somehow L ever makes it past the MHRA it'll likely be a year before NICE responds, so 2026 now.

Hey, maybe NICE will allow a sweet "Cost plus" contract like LP did for Advent?? Eye rolls.
NWBO
Monksdream Monksdream 3 minutes ago
SHW new 52 week high
https://investorshub.advfn.com/uimage/uploads/2024/7/26/vdyxbIMG_9998.gif
SHW
okwife okwife 3 minutes ago
how much is the acquisition worth?
IJJP
ap17 ap17 4 minutes ago
yep. lol
XRPUSD
blackhawks blackhawks 4 minutes ago
Who is more likely to look comprehensively at presidential performance, you or university professors?
surfer44 surfer44 4 minutes ago
Talking about subpenny stocks. Most are for the dogpile but there is always the exception. Sell in May and go away?

PayPal founder Peter Thiel amassed $5B fortune in Roth IRA, tax leak reveals
By
Zachary Halaschak
June 24, 2021 6:34 pm
.
Billionai
chazzy1 chazzy1 4 minutes ago
Drhome, now that I see where judge Starr dismissed the case without prejudice, I don't see this as negative news. Please see my post (131656).
VPLM
boston745 boston745 4 minutes ago
I wasnt suggesting ihub hire, the community would handle the verification and adding verification links of their own volition. I post links as well but that information can quickly be drowned out which is why i was suggesting an area for it so others can access easier. Sort of like pinned posts but
FreeMind7 FreeMind7 4 minutes ago
what made you go long at 215?
TSLA
DewDiligence DewDiligence 5 minutes ago
DXCM—(-42%)—posts soft 2Q24 results—slashes guidance:

https://finance.yahoo.com/news/dexcom-reports-second-quarter-2024-200300596.html

This is DXCM’s biggest 1-dat loss ever. The problem is not GLP-1 drugs, but rather the loss of market share to ABT in the CGM arena.
ABT GLP
m0n m0n 5 minutes ago
LoL Citron has nothing to do w/ I FU S

IFUS
rolvram rolvram 5 minutes ago
Having worked with AI, quantum computing and semiconductors for a few decades I think very few understand what's happening. Nvidia is positioned better than anyone. It's a matter of very short time IMHO
NVDA
m0n m0n 6 minutes ago
Increase sales? Hypothetical statement right there LoL.

14 years of having products on the market and the industry truly doesn’t care based on sale numbers.

No One is Fooled
IFUS
TAZMANS TAZMANS 6 minutes ago
Good question, technology upgrades are now moving at light speed!

For now, the one upside, IMO, is that this one has an "old look" and very user-friendly feel, simple but powerful vs some very hi-tech competitors.

The downside is the mismanagement of the boards related
DewDiligence DewDiligence 6 minutes ago
DXCM—(-42%)—posts soft 2Q24 results—slashes guidance:

https://finance.yahoo.com/news/dexcom-reports-second-quarter-2024-200300596.html

This is DXCM’s biggest 1-day loss ever. The problem is not GLP-1 drugs, but rather the loss of market share to ABT in the CGM arena.
ABT GLP
LVerstee LVerstee 6 minutes ago
Budget......
ITUP
SSKILLZ1 SSKILLZ1 6 minutes ago
BMY

Don't know how the great the call was. Selling it in the 41's and made a small profit. Furthermore I said this before the earnings yesterday, I wouldn't take the risk into earning in the 45's if I still owned it, and that call wasn't great either. Can't say I'm too happy pick a st
BMY
Slaytanic420 Slaytanic420 6 minutes ago
The RV permits where fake, the plates don't exist wrs456 on the blockchain which means its fabricated and lies like bfs Linkin says he went to Yale
HMBL
RickNagra RickNagra 7 minutes ago
Oh wow.
ERBB
ipiros ipiros 7 minutes ago
https://x.com/prospect_empire/status/1816886971551146092?s=46&t=1mtQtgXmx35-BlWutjUYiQ
HIRU